Home › Funds › Entropy Technologies, LP › ALNY

Entropy Technologies, LP position in ALNY

ALNYLAM PHARMACEUTICALS INC · Health Care

Entropy Technologies, LP reported holding 41,204 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$12.4M, representing 0.49% of its reported portfolio and ranking #42 among its reported holdings. Entropy Technologies, LP has disclosed ALNY holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)41.20K sh
Reported value held$12.40M
Portfolio Weight0.49%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Entropy Technologies, LP's ALNY position evolved

Entropy Technologies, LP first disclosed a stake in ALNY in Q2 2024 at 6,849 shares (US$1.7M). The position peaked in Q2 2026 at 41,204 shares, worth US$12.4M. Across 6 filings, Entropy Technologies, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 41,204 shares valued at US$12.4M — an increase of 5,485 shares quarter over quarter.. Notable position changes include a 1462% increase in Q3 2025 (shares fell 13% over the following quarter), a 122% increase in Q1 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 6.85K $1.66M New
Q2 2025 1.10K $358.70K New
Q3 2025 17.18K $7.83M Add
Q4 2025 16.10K $6.40M Reduce
Q1 2026 35.72K $11.82M Add
Q2 2026 41.20K $12.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALNY and 13F data

ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$734.5M), Orbis Allan Gray Ltd (US$598.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALNY

All ALNY fund holders →

FAQ

How long has Entropy Technologies, LP held ALNY?

Entropy Technologies, LP has disclosed ALNY holdings in 6 of the last 9 reported quarters, going back to Q2 2024.

What is Entropy Technologies, LP's current position in ALNY?

As of Q2 2026, Entropy Technologies, LP holds 41.20K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $12.40M, representing 0.49% of its reported portfolio and ranking #42.

Has Entropy Technologies, LP been buying or selling ALNY?

In the latest 13F filing (Q2 2026), Entropy Technologies, LP increased its position in ALNY. The position peaked in Q2 2026 at 41.20K shares.

Which other funds hold ALNY?

Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.